STLN
Starling Oncology, Inc.
Latest Form 4:Sale$1.9MbyHively Brad (Director) · filed Aug 24, 2026
Starling Oncology, Inc. (STLN) has 2 SEC Form 4 filings (2 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Aug 24, 2026.
Insiders have net sold $1.9M over the trailing 6 months.
- Industry:Medical - Care Facilities
- Employees:641
- HQ:Cerritos, CA, US
- IPO:2026-08-04
Insider Buying
$78K
reported purchases (SEC code P)
Insider Selling
$1.9M
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Market Cap
$628.8M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Hively BradFirst in 8 months | Director | Sale | 298,853 | $1.9M | Aug 24 | SEC ↗ |
| 10% Owner | Purchase | 12,000 | $78K | Aug 17 | SEC ↗ |
Related companies
Starling Oncology, Inc. is in the Healthcare sector.